The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors
Journal of Nuclear Medicine · 2023
DOI: 10.2967/jnumed.122.264422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Elif Hindié und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, CHU de Bordeaux, University of Bordeaux, Bordeaux, France; elif.hindie@chu-bordeaux.fr. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatic Neoplasms, Stomach Neoplasms, Intestinal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
We would like to draw attention to the latest advances in the field of peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors (NETs) of gastroenteropancreatic origin. The term NET refers to well-differentiated tumors that can be grade 1 (Ki-67 index,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, CHU de Bordeaux, University of Bordeaux, Bordeaux, France; elif.hindie@chu-bordeaux.fr.
- Department of Endocrine Oncology and Imaging, Gustave Roussy Cancer Campus, Villejuif, France.
- Department of Medicine, St. Vincent's Hospital Medical School, University of Melbourne, Melbourne, Victoria, Australia; and.
- Department of Nuclear Medicine, La Timone Hospital, Aix-Marseille University, Marseille, France.
Zitieren
APA
Hindié, E., Baudin, E., Hicks, R. J., & Taïeb, D. (2023). The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.122.264422
Vancouver
Hindié E, Baudin E, Hicks RJ, Taïeb D. The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.122.264422
BibTeX
@article{Hindi2023,
author = {Hindié, Elif and Baudin, Eric and Hicks, Rodney J and Taïeb, David},
title = {The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors},
journal = {Journal of Nuclear Medicine},
year = {2023},
doi = {10.2967/jnumed.122.264422}
}
EUVIMED